Follow
Markku Laakso
Markku Laakso
Professor of Internal Medicine, University of Eastern Finland
Verified email at uef.fi
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
66528*2016
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
SM Haffner, S Lehto, T Rönnemaa, K Pyörälä, M Laakso
New England journal of medicine 339 (4), 229-234, 1998
101331998
Analysis of protein-coding genetic variation in 60,706 humans
M Lek, KJ Karczewski, EV Minikel, KE Samocha, E Banks, T Fennell, ...
Nature 536 (7616), 285-291, 2016
101122016
“Effective” number of parties: a measure with application to West Europe
M Laakso, R Taagepera
Comparative political studies 12 (1), 3-27, 1979
59111979
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a …
JA Dormandy, B Charbonnel, DJA Eckland, E Erdmann, ...
The Lancet 366 (9493), 1279-1289, 2005
52272005
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
M Lagouge, C Argmann, Z Gerhart-Hines, H Meziane, C Lerin, F Daussin, ...
Cell 127 (6), 1109-1122, 2006
47282006
Genetic studies of body mass index yield new insights for obesity biology
AE Locke, B Kahali, SI Berndt, AE Justice, TH Pers, FR Day, C Powell, ...
Nature 518 (7538), 197-206, 2015
45822015
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
A Keech, RJ Simes, P Barter, J Best, R Scott, MR Taskinen, P Forder, ...
Lancet (London, England) 366 (9500), 1849-1861, 2005
35412005
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
JL Chiasson, RG Josse, R Gomis, M Hanefeld, A Karasik, M Laakso
The Lancet 359 (9323), 2072-2077, 2002
35382002
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
EK Speliotes, CJ Willer, SI Berndt, KL Monda, G Thorleifsson, AU Jackson, ...
Nature genetics 42 (11), 937-948, 2010
35052010
Discovery and refinement of loci associated with lipid levels
Nature genetics 45 (11), 1274-1283, 2013
28882013
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
J Dupuis, C Langenberg, I Prokopenko, R Saxena, N Soranzo, ...
Nature genetics 42 (2), 105-116, 2010
24762010
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial
JL Chiasson, RG Josse, R Gomis, M Hanefeld, A Karasik, M Laakso, ...
Jama 290 (4), 486-494, 2003
23002003
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
CKDGen Consortium, KidneyGen Consortium, EchoGen consortium, ...
Nature 478 (7367), 103-109, 2011
22752011
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes
E Zeggini, LJ Scott, R Saxena, BF Voight, JL Marchini, T Hu, ...
Nature genetics 40 (5), 638-645, 2008
22612008
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ...
The Lancet 368 (9541), 1096-1105, 2006
22242006
† Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text‡: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology …
L Ryden, E Standl, M Bartnik, GV Berghe, J Betteridge, MJ De Boer, ...
European heart journal supplements 9 (suppl_C), C3-C74, 2007
21982007
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
BF Voight, LJ Scott, V Steinthorsdottir, AP Morris, C Dina, RP Welch, ...
Nature genetics 42 (7), 579-589, 2010
21522010
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC ...
Nature genetics 44 (9), 981-990, 2012
21292012
Defining the role of common variation in the genomic and biological architecture of adult human height
AR Wood, T Esko, J Yang, S Vedantam, TH Pers, S Gustafsson, AY Chu, ...
Nature genetics 46 (11), 1173-1186, 2014
20592014
The system can't perform the operation now. Try again later.
Articles 1–20